TY  - JOUR
AU  - Daudén Tello, E
AU  - Alonso Suárez, J
AU  - Beltrán Catalán, E
AU  - Blasco Maldonado, C
AU  - Herrero Manso, M C
AU  - Jiménez Morales, A
AU  - Marín-Jiménez, I
AU  - Martín-Arranz, M D
AU  - García-Merino, A
AU  - Porta Etessam, J
AU  - Rodríguez-Sagrado, M A
AU  - Rosas Gómez de Salazar, J
AU  - Trujillo Martín, E
AU  - Salgado-Boquete, L
PY  - 2020
DO  - 10.1016/j.ad.2020.08.007
UR  - http://hdl.handle.net/10668/16239
T2  - Actas dermo-sifiliograficas
AB  - We present a series of general and specific recommendations based on pathophysiologic considerations for managing the most common adverse effects of apremilast that lead to treatment discontinuation: diarrhea, nausea, and headache. The recommendations...
LA  - en
KW  - Adverse effects
KW  - Apremilast
KW  - Cefalea
KW  - Diarrea
KW  - Diarrhea
KW  - Efectos adversos
KW  - Headache
KW  - Nausea
KW  - Náuseas
KW  - Psoriasis
KW  - Combined Modality Therapy
KW  - Diarrhea
KW  - Disease Management
KW  - Headache
KW  - Humans
KW  - Nausea
KW  - Patient Care Team
KW  - Phosphodiesterase 4 Inhibitors
KW  - Practice Guidelines as Topic
KW  - Psoriasis
KW  - Thalidomide
TI  - Multidisciplinary Management of the Adverse Effects of Apremilast.
T2  - Manejo de los efectos adversos de apremilast desde un abordaje multidisciplinar.
TY  - research article
VL  - 112
ER  -